268 results about "Fluorobenzene" patented technology

The invention provides a novel method for synthesizing 1, 4-bis (4-fluorobenzoyl) benzene, which belongs to the technical field of aromatic halide production, and comprises the following steps: under inert gas, adding supported solid acid and fluorobenzene into a reaction container; the preparation method comprises the following steps: dropwise adding paraphthaloyl chloride into a reaction container, and reacting at 5-30 DEG C for 1-8 hours to obtain 1, 4-bis (4-fluorobenzoyl) benzene; carrying out purification treatment on the reaction system to obtain 1, 4-bis (4-fluorobenzoyl) benzene with the purity of 97.2% or above; the supported solid acid is composed of a carrier and Lewis acid; lewis acid is selected from any one of aluminum chloride, ferric chloride, titanium tetrachloride and zinc chloride; the carrier is selected from any one of an HY molecular sieve, an Hbeta molecular sieve, a ZSM-5 molecular sieve, acid-treated K10 montmorillonite, aluminum oxide and an MCM-41 molecular sieve. The reaction system condition is mild, the product purity is larger than or equal to 97.2%, after the condition is optimized, the purity is larger than 99.5%, the product and the catalyst can be separated through filtering, waste salt is avoided, the catalyst can be recycled, and the reaction is green and environmentally friendly.

Methods for treating immune thrombocytopenia comprising administering at least one compound chosen from (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile (PRN1008) and pharmaceutically acceptable salts thereof are disclosed. Pharmaceutical compositions comprising at least one compound chosen from PRN1008 and pharmaceutically acceptable salts thereof are also disclosed.

The invention discloses a low-cost and environment-friendly process for producing 1, 4-bis (4-fluorobenzoyl) benzene, and belongs to the technical field of Friedel-Craft reaction, fluorobenzene and paraphthaloyl chloride react to generate 1, 4-bis (4-fluorobenzoyl) benzene, after reaction quenching, filtering is performed to obtain a crude product 1, 4-bis (4-fluorobenzoyl) benzene and filtrate, and the 1, 4-bis (4-fluorobenzoyl) benzene is purified in a sublimation crystallization mode; standing and layering the filtrate in an inclined plate layering device, respectively treating an oil layer and a water layer, dehydrating a fluorobenzene layer in a dehydrating tower, and returning fluorobenzene; the water phase is firstly subjected to organic matter removal treatment, the obtained organic matter enters a fluorobenzene recovery device to be sleeved back, and the obtained water phase is a byproduct of crystallized aluminum chloride in an evaporative crystallization device. According to the process, the 1, 4-bis (4-fluorobenzoyl) benzene is produced in a sublimation crystallization mode instead of a solution crystallization mode, no waste solvent is generated, the waste solvent does not need to be recycled, the cost is low, organic matter removal and evaporative crystallization treatment is carried out on wastewater, organic matter recycling is carried out, crystalline aluminum chloride is produced as a byproduct, and wastewater and waste salt are not discharged.

The invention provides a perovskite passivation layer and a preparation method thereof. According to the invention, a perovskite passivation layer is arranged on the surface of a perovskite absorption layer, and the material of the perovskite passivation layer contains an alkyl diamine compound and a phenylethyl ammonium compound; the phenethyl ammonium compound is selected from p-trifluoromethyl phenylethylamine hydrochloride and / or p-fluorophenethyl hydriodate. According to the perovskite solar cell and the preparation method thereof, the alkyl diamine compound and the phenylethyl ammonium compound are cooperated to form the passivation layer, the simultaneous effect of surface passivation and interface passivation can be exerted, the carrier recombination of the surface and the interface is reduced, the electron extraction capability is improved, and the energy conversion efficiency of the perovskite solar cell is further improved.

The invention relates to a non-aqueous electrolyte and a lithium secondary battery. In order to solve the problems of poor cycle performance, high impedance and serious gas production of a lithium secondary battery, the invention provides a non-aqueous electrolyte, the non-aqueous electrolyte comprises an organic solvent, a lithium salt and additives, the additives comprise a first additive, a second additive and a third additive, the first additive is selected from one or more of compounds shown in a formula I, and the third additive is selected from one or more of compounds shown in a formula II; the formula I is # imgabs0; the second additive is selected from a compound shown in a formula II and / or a formula III; the formula II is # imgabs 1 #, the formula III is # imgabs 2 #, and the third additive is selected from one or more of double-bond-containing cyclic carbonate, halogen-containing cyclic carbonate, sulfonate, sulfate, sulfite, anhydride, a benzene compound, a fluorobenzene compound, a nitrile compound, phosphate, phosphite, a boron compound, an amine compound, a silicon-containing compound and a heterocyclic compound. Through the synergistic effect of the three additives, the cycle performance of the battery is improved, the impedance of the battery is reduced, and the gas production of the battery is reduced.

The invention discloses a fluorescent covalent organic framework material for hydrogen sulfide detection as well as a preparation method and application thereof, relates to a covalent organic framework material as well as a preparation method and application thereof, and aims to solve the technical problems that an existing porous material for H2S detection is few in structure type, unstable in COFs (Covalent Organic Frameworks) structure, high in detection limit and harsh in detection environment. The periodic structure fragment of the fluorescent covalent organic framework material for hydrogen sulfide detection is shown in the specification. 3-(5, 10-diamino-1H-phenanthrene) [9, 10-d] imidazole-2-yl) phenol and 2, 4, 6-tri (4-formylphenoxy)-1, 3, 5-triazine are subjected to a reaction to obtain a hydroxyl intermediate, the hydroxyl intermediate is modified with 2, 4-dinitrofluorobenzene, and the fluorescent material is used for qualitative detection of H2S. The method is not interfered by amino acids and anions in the environment, and is not influenced by an acid-base environment. The method can be used in the field of H2S detection.

The invention discloses a preparation method for green synthesis of 1, 4-bis (4-fluorobenzoyl) benzene, and belongs to the technical field of Friedel-Craft reaction, an ionic liquid is used as a catalyst to catalyze the reaction of fluorobenzene and paraphthaloyl chloride to generate the 1, 4-bis (4-fluorobenzoyl) benzene, and the 1, 4-bis (4-fluorobenzoyl) benzene is used as a catalyst to catalyze the reaction of fluorobenzene and paraphthaloyl chloride to generate the 1, 4-bis (4-fluorobenzoyl) benzene. And the ionic liquid is one or more of [Bmim] Cl / AlCl3, [Bmim] Br / AlCl3, [Emim] Cl / AlCl3, [Emim] Br / AlCl3, C4H9NBr / AlCl3, Et3NHCl / AlCl3, [Emim] Cl-AlCl3-MgCl2, [Bmim] Cl-AlCl3-CuCl and [Moemim] Br / AlC13. The invention further discloses a preparation method of the ionic liquid. According to the ionic liquid, fluorobenzene and paraphthaloyl chloride can be converted into 1, 4-bis (4-fluorobenzoyl) benzene at room temperature, long-time backflow at the boiling point of fluorobenzene is not needed, and the reaction safety is high; after the reaction is finished, the ionic liquid can be separated from a reaction system through standing and layering, and the separation steps are simple; after the reaction is finished, the catalyst does not need to be quenched, can be recycled, does not generate waste salt and is green and environment-friendly; the product yield is 96.48%-99.87%, the product purity is 99.62%-99.92%, and the product yield is high.

The invention relates to L-threonine aldolase, in particular to an L-threonine aldolase mutant R318L / H128N / N90Q and application of the L-threonine aldolase mutant R318L / H128N / N90Q. The amino acid sequence of the L-threonine aldolase mutant is shown as SEQ ID NO: 3, and the L-threonine aldolase mutant is obtained by changing the 318th amino acid of L-threonine aldolase of which the amino acid sequence is SEQ ID NO: 1 into Leu from Arg, changing the 128th amino acid into Asn from His and changing the 90th amino acid into Gln from Asn. The mutant has high catalytic activity in a reaction of catalyzing benzaldehyde and derivatives thereof and glycine to synthesize beta-hydroxyl-alpha-amino acid, when a whole cell expressing R318L / H128N / N90Q is used for catalysis, the diastereoselectivity (de) of benzaldehyde and glycine to synthesize benzene serine is 65.8%, and the yield is 67.7%; the diastereoselectivity (de) of p-fluorobenzene serine synthesized from p-fluorobenzaldehyde and glycine is 77.5%, and the yield of p-fluorobenzene serine is 80.3%. The mutant has application potential in biosynthesis of beta-hydroxyl-alpha-amino acid.

Methods for treating patients with chronic spontaneous urticaria (CSU) comprising administering at least one compound chosen from (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxyphenyl) pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile (rilzabrutinib) and pharmaceutically acceptable salts thereof are disclosed.

Methods for treating immune thrombocytopenia comprising administering at least one compound chosen from (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile (rilzabrutinib) and pharmaceutically acceptable salts thereof are disclosed.

The present invention relates to a ternary insecticidal composition of 3-[benzoyl(methyl)amino]-N-[2-bromo-4-(1,1,1,2,3,3,3-heptafluoropropan-2-yl)- 6-(trifluoromethyl)phenyl]-2-fluorobenzamide (Component A), 4-chloro-5-ethyl-2-methyl-N-[[4-(4-methylphenoxy)phenyl]methyl] pyrazole-3-carboxamide (Component B) and at least one insecticide (Component C) demonstrating an effective and synergistic broad spectrum control of insects-pests and mites with one shot application by developing delay in resistance of hard to kill and resistant towards insects-pests and mites Further, the ternary insecticidal composition provides residual control and increases yield of treated plants due to protection against insect-pests and mites. The ternary insecticidal composition of present invention increases overall health and plant vigor and is environmentally safe.

The invention discloses a high-purity fluorobenzene recovery process in 1, 4-bis (4-fluorobenzoyl) benzene production, and belongs to the technical field of organic waste liquid recovery, the process comprises the following steps: 1, enabling fluorobenzene waste liquid to pass through a tubular reactor filled with anhydrous aluminum chloride particles to react to obtain dewatered fluorobenzene waste liquid, the reaction temperature is 5-40 DEG C, the retention time is 60-200min, and the flow velocity of the fluorobenzene waste liquid is 0.1-0.4 m / min; 2, the water-removed fluorobenzene waste liquid is filtered through a micron filter and then enters a fluorobenzene rectifying tower to be rectified, organic steam on the tower top is compressed through a compressor, subjected to heat exchange through an MVR heat exchanger and condensed and then enters a reflux tank to be refluxed, high-purity fluorobenzene is extracted from the fluorobenzene rectifying tower, the purity of the fluorobenzene is larger than 99.99 wt%, and the mass content of water is smaller than 10 ppm. The fluorobenzene waste liquid in the production process of 1, 4-bis (4-fluorobenzoyl) benzene is used as a raw material, continuous batch production of high-purity fluorobenzene is achieved through reaction dehydration, crystalline aluminum chloride filtration and rectification, the process is simple, and energy consumption is low.

Methods for treating patients with moderate-to-severe asthma comprising administering a therapeutically effective amount of at least one compound chosen from (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile (rilzabrutinib) and pharmaceutically acceptable salts thereof are disclosed.

The invention discloses a method for preparing bisphenol A and a heterocyclic compound by utilizing waste PC (polycarbonate), and belongs to the technical field of solid waste recycling, the method comprises the following steps: constructing a reaction system by utilizing crushed waste PC, an aminobenzonitrile compound, an alkali catalyst and a solvent, and reacting the reaction system at the temperature of 100-160 DEG C for more than or equal to 30 minutes in an air atmosphere to obtain the bisphenol A and heterocyclic compound. According to the method, bisphenol A and a heterocyclic compound are taken as raw materials, and the heterocyclic compound is quinazoline-2, 4 (1H, 3H)-diketone or a derivative of quinazoline-2, 4 (1H, 3H)-diketone; the amino benzonitrile compounds comprise 2-amino benzonitrile, 2-amino-5-fluorobenzonitrile, 2-amino-4-chlorobenzonitrile and the like; the solvent comprises water and an organic solvent. According to the method, double upgrading conversion of the waste PC can be achieved, the reaction products bisphenol A and the quinazoline-2, 4 (1H, 3H)-diketone compound can be obtained at the same time, the reaction condition is mild, the reaction speed is high, and the method has wide application prospects in the aspect of high-value utilization of the waste PC.

The invention relates to a method for preparing a rosuvastatin calcium intermediate, and belongs to the technical field of drug intermediate synthesis. The method comprises the following steps: under the protection of nitrogen, carrying out reflux reaction on raw materials including 4-fluorobenzaldehyde and ethyl 4-methyl-3-oxovalerate under the catalysis of piperidine acetate and a co-catalyst, and carrying out reduced pressure distillation recovery to obtain a compound shown as a formula V; dropwise adding 2-ethyl-2-isothiourea and a compound shown in a formula VI, carrying out cyclization reaction under a non-violent reflux condition, and then adding DDQ in batches for oxidation to obtain a compound shown in a formula IV; oxidizing the compound as shown in the formula IV, and immediately quenching by using saturated NaHCO3 after the reaction is finished to obtain a compound as shown in a formula III; the preparation method comprises the following steps: firstly, treating a compound shown as a formula III by using methylamine, and slowly dropwise adding methylsulfonyl chloride under ice bath temperature control to obtain a compound shown as a formula II; reducing the ester group of the compound shown in the formula II in anhydrous toluene by using DIBAL to obtain an alcohol intermediate; then, selective oxidation is performed to obtain a final product; the method integrally has the advantages of high product yield and purity, few byproducts and low production difficulty.

The invention discloses a method for preparing a fluorobenzene derivative from diazonium salt of substituted aniline, which comprises the following steps: carrying out ion exchange reaction on diazonium fluoroborate of substituted aniline at low temperature in the presence of a solvent and anhydrous hydrogen fluoride, and then heating and decomposing to obtain the fluorobenzene derivative. The method avoids the generation of water and boron trifluoride in the existing fluorobenzene derivative preparation process, and is beneficial to industrial application.

Methods for treating patients with wAIHA comprising administering at least one compound chosen from (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile (rilzabrutinib) and pharmaceutically acceptable salts thereof are disclosed.

The invention provides a 3-amino-2-fluorobenzamide compound and a preparation method thereof, and the preparation method comprises the following steps: (1) carrying out a substitution reaction on 5-chloro-2-hydroxy-3-nitrobenzoic acid to obtain 5-chloro-2-fluoro-3-nitrobenzoyl halide with a structure as shown in a formula I; (2) carrying out an amidation reaction on the 5-chloro-2-fluoro-3-nitrobenzoyl halide and an aniline compound with a structure as shown in a formula II to obtain a 3-nitro-2-fluorobenzamide compound with a structure as shown in a formula III; and (3) carrying out a reduction reaction on the 3-nitro-2-fluorobenzamide compound, so as to obtain the 3-amino-2-fluorobenzamide compound with a structure as shown in a formula IV. The preparation method is low in raw material price, almost quantitative in multi-step reaction, few in by-products, high in target product yield and mild in process condition, avoids severe reaction conditions such as deep cooling and high temperature, and is more suitable for industrial production.

The invention relates to a lithium ion electrolyte and a battery, and belongs to the technical field of lithium ion batteries. The lithium ion electrolyte comprises a lithium salt, an organic solvent and a first additive, wherein the organic solvent comprises a first solvent, and the first solvent is selected from carbonic ester compounds substituted by hydrogen, C1-C5 alkyl, phenyl and tolyl; the first additive is selected from hydrogen, fluorine and cyano-substituted nitrile fluorobenzene compounds; in percentage by mass, the content of the first additive in the electrolyte is b% and is smaller than or equal to blt; 5. By adopting a specific type of electrolyte solvent and additive combination, the stability of an electrolyte-positive electrode / negative electrode interface can be improved, the high-temperature performance of the LCO-Gr system lithium ion battery under high voltage is remarkably improved, and the high-temperature cycle performance, the standing cycle performance, the high-temperature storage performance and the like are improved.

The invention discloses a preparation method of fiazonetin, and belongs to the technical field of medicinal chemistry. According to the route, 2-halo-3-methylpyrazine which is low in price and easy to obtain is used as a raw material and sequentially reacts with hydrazine hydrate and orthoester, and then a hydrogenation reduction reaction is performed to generate a compound 4; carrying out chiral resolution or chiral separation on the compound 4 and carrying out condensation reaction on the compound 4 and p-fluorobenzoyl halide to obtain an intermediate compound 5 or 5'and a new intermediate compound 6; reacting the compound 6 with a halogenating reagent to obtain a compound 7; carrying out Suzuki coupling reaction on the compound 7 and a compound 8 to obtain a compound, namely, the compound of the formula A, namely, non-azonepan; according to the route, the raw materials are simple, easy to obtain and low in cost; the reaction is simple, the preparation efficiency is high, and the reaction yield of each step can be higher than 90%; no harsh reaction conditions exist, and operation is safe; post-treatment is simple and convenient, and environmental pollution is low. The method is suitable for large-scale production; a high-chiral product can be obtained, the chiral purity value of a final product is as high as 99.5%, and the method has relatively good market value and profound practical significance. # imgabs0 #

The invention discloses a method for synthesizing a chlorfenapyr bisamide intermediate by a one-pot method, which comprises the following steps: by taking aniline as an initial raw material, reacting the aniline with 2-bromoheptafluoropropane under the action of a catalyst and an acid-binding agent to generate 4-heptafluoroisopropylaniline, distilling to recover excessive 2-bromoheptafluoropropane after the aniline is completely converted, and separating the 2-bromoheptafluoropropane from the 4-heptafluoroisopropylaniline to obtain the chlorfenapyr bisamide intermediate. Adding bromotrifluoromethane into the reaction liquid to react to obtain 2-trifluoromethyl-4-(heptafluoroisopropyl) aniline, then carrying out oxidation-reduction reaction on the dropped hydrogen peroxide and excessive sodium hydrosulfite, and after the sodium hydrosulfite is completely consumed, reacting to obtain 2-trifluoromethyl-4-(heptafluoroisopropyl) aniline; and carrying out benzene ring bromination reaction on dropwise added hydrogen peroxide, the brominating agent in the reaction liquid and the 2-trifluoromethyl-4-(heptafluoroisopropyl) aniline to obtain the 2-bromo-4-(heptafluoroisopropyl)-6-(trifluoromethyl) aniline, wherein the brominating agent in the reaction liquid and the 2-trifluoromethyl-4-(heptafluoroisopropyl)-6-(trifluoromethyl) aniline are subjected to benzene ring bromination reaction. The method is simple in process, high in yield, low in raw material cost and suitable for industrial production.

Methods for treating immune thrombocytopenia comprising administering at least one compound chosen from (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile (PRN1008) and pharmaceutically acceptable salts thereof are disclosed. Pharmaceutical compositions comprising at least one compound chosen from PRN1008 and pharmaceutically acceptable salts thereof are also disclosed.

Methods for treating Sickle Cell Disease (SCD) comprising administering a BTKi, such as at least one compound chosen from (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile (rilzabrutinib) and pharmaceutically acceptable salts thereof, are disclosed.

The present invention relates to a process for the preparation of a compound of formula (I), a stereoisomer, a salt, a hydrate or a solvate thereof, (II) comprising the step of sulfinylation of a compound of formula (IV) to produce compound of formula (II); (IV) wherein: R1 and R2 are as defined in the claims, wherein said sulfinylation step is performed in the presence of a solvent selected from the group comprising benzene, toluene, ethylbenzene, xylene, chlorobenzene, bromobenzene, fluorobenzene, anisole, nitrobenzene, tetralin, dichlorobenzene, trimethylbenzene, ethylacetate, propylacetate, butylacetate, propanol, butanol, 2- methyltetrahydrofuran, diethylether, methyltertbutylether, cyclopentyl methyl ether, dichloromethane, tetrachloromethane, pentane, hexane, heptane, cyclohexane, decaline and mixtures thereof.

Disclosed herein are novel formulations of 2-[(3R)-2-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4[4-(oxetan-3-yl)piperazin-1-yl]-pent-2-enenitrile, including formulations including various solid forms thereof. Also disclosed are processes for preparing formulations of 2-[(3R)-2-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4[4-(oxetan-3-yl)piperazin-1-yl]-pent-2-enenitrile.

The invention discloses a local high-concentration high-voltage electrolyte, a preparation method and a battery, and belongs to the technical field of electrolytes. The local high-concentration high-voltage electrolyte comprises a sodium salt, a first solvent and a second solvent, the first solvent comprises carbonic ester, the second solvent comprises at least one of a fluoroether solvent and a fluorobenzene solvent, the first solvent and the second solvent are mutually soluble, the solubility of the sodium salt in the first solvent is defined as S1, the solubility of the sodium salt in the second solvent is defined as S2, and S1 is larger than S2. According to the electrolyte, the overall salt concentration can be reduced, the viscosity of the electrolyte can be reduced, the wettability of the electrolyte can be improved, so that the conductivity of ions is improved, in addition, oxygenolysis of the first solvent can be slowed down, and furthermore, the second solvent has high oxidation resistance and oxidation resistance, so that the service life of the electrolyte is prolonged. And the oxygenolysis of the electrolyte under a high-voltage condition can be inhibited, so that the cycling stability of the battery can be improved, the battery capacity is improved, and the battery is suitable for a high-voltage application scene.

The invention relates to the technical field of p-fluorobenzaldehyde production, and particularly discloses a production process of high-purity p-fluorobenzaldehyde. The invention relates to a production process of high-purity p-fluorobenzaldehyde. The production process comprises the following steps: S1, carrying out a chlorination reaction by taking p-fluorotoluene and chlorine as raw materials to prepare a mixed chlorination solution of p-fluoromethyl benzyl monochloride, p-fluoromethyl benzyl dichloride and p-fluoromethyl benzyl trichloride; s2, adding an organic complexing agent, which is a water-soluble aprotic solvent, into the mixed chlorinated liquid prepared in the step S1, and then performing vacuum rectification to obtain distillate and residual liquid; rectifying by taking the residual liquid as a raw material to obtain kettle liquid and rectified liquid; and S3, carrying out hydrolysis reaction by taking the rectification liquid and water as raw materials, separating, and drying to obtain the product. The production process of the high-purity p-fluorobenzaldehyde has the advantages of high raw material conversion rate, high product purity and few three-waste products.

The invention discloses a preparation method of a dapagliflozin intermediate 5-bromine-2-chlorine-4 '-ethyoxyl diphenylmethane, which comprises the following steps: carrying out nucleophilic substitution reaction on 4-bromine-1-chlorine-2-fluorobenzene and 4-ethyoxyl phenylacetate, and then hydrolyzing and decarboxylating to obtain the dapagliflozin intermediate 5-bromine-2-chlorine-4'-ethyoxyl diphenylmethane. By optimizing the preparation route, the reaction utilization rate, the product yield and the product purity of the raw materials are improved, high-risk and high-pollution chemicals are prevented from being used, and the method is convenient to operate, safe, environmentally friendly, efficient in reaction and beneficial to industrial implementation.

The invention discloses a preparation method of an omariglone key intermediate, which comprises the following steps: under the common catalytic action of a catalyst and a ligand, taking 4-bromo-2, 6-dimethyl fluorobenzene and hydrazine hydrate as initial raw materials, adding an additive and a solvent, and synthesizing the omariglone key intermediate under a heating condition. The preparation method provided by the invention is simple to operate, mild in reaction condition and high in atom economy, the synthesis cost is reduced, and industrial-grade large-scale production is realized.

The invention discloses a synthesis method of Peniterpheyl A. According to synthesis of a key structural unit furan ring, diphenyl ether is synthesized through a simple heating substitution reaction of a phenol derivative and a fluorobenzene derivative, then C-C direct oxidative coupling of double benzene rings in a molecule is achieved under a Pd / Ag catalytic system to synthesize the furan ring, and due to steric hindrance and guiding group effects, the furan ring can be synthesized into the furan ring. The product has high selectivity, does not need harsh reaction conditions, has simple synthesis steps, is suitable for large-scale production, does not need to widely screen specific strains and fermentation conditions compared with a method for obtaining a low-amount target compound from microbial fermentation separation, is simple and efficient, and can guarantee a large amount of compounds required by subsequent research and development.